Article
Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox".
Lung cancer (Amsterdam, Netherlands) - 1 Nov 2015
Arrieta Oscar, Ramírez-Tirado Laura-Alejandra, Báez-Saldaña Renata, Peña-Curiel Omar, Soca-Chafre Giovanny, Macedo-Perez Eleazar-Omar
Abstract excerpt
OBJECTIVE: Sixteen percent of US population is Hispanic, mostly Mexican. Recently, two independent American reports demonstrated a higher overall survival (OS) in Hispanic populations compared with non-Hispanic-white populations (NHW) with non-small-cell lung cancer (NSCLC), even when most Hispanic patients are diagnosed at advanced disease stages and have lower income status. We analyzed the clinical,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
